Pfizer and Moderna both issued huge 2022 revenue ($50B) guidance to Wall Street for Covid-19 vaccines.
https://twitter.com/rubiconcapital_/status/1505663784307896323?s=12
Moderna: "We have signed advanced purchase agreements for expected delivery in 2022 in the amount of approximately $19 billion and signed option agreements for delivery in 2022 of approximately $3 billion."
Pfizer: "We now expect the Covid-19 vaccine revenue for the year to be approximately $32 billion, an increase of approximately $1 billion."
Comments
Post a Comment